Sort
10,766 grants matching “checkpoint inhibitor”
Targeting macrophages to sensitize myeloma to immune checkpoint blockade
$328,888Qing Yi · Cleveland Clinic Lerner Com-Cwru · R01 · FY2018 · CA
Development of novel metastatic mouse models that recapitulate the major immune contexts of human colon cancer
$328,798Tyler E Jacks · Massachusetts Institute Of Technology · R01 · FY2021 · CA
Reprogramming the TME for immunogenic antigen-presentation
$328,641David H Munn · Augusta University · R01 · FY2020 · CA
Rational Sequencing of PD-1 and CTLA-4 Antibodies in Metastatic Melanoma
$328,454Jeffrey S Weber · H. Lee Moffitt Cancer Ctr & Res Inst · R01 · FY2015 · CA
A Regulatory Checkpoint in the Pathogenesis of Inflammatory Arthritis
$328,313Christian Stehlik · Northwestern University At Chicago · R01 · FY2014 · AR
A Regulatory Checkpoint in the Pathogenesis of Inflammatory Arthritis
$328,313Christian Stehlik · Northwestern University At Chicago · R01 · FY2013 · AR
A Regulatory Checkpoint in the Pathogenesis of Inflammatory Arthritis
$328,313Christian Stehlik · Northwestern University At Chicago · R01 · FY2015 · AR
Enhancing the Potency and Durability of Immunotherapies
$328,134Robert C Seeger · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Exploiting Therapeutic Vulnerabilities
$328,133William A Weiss · Children'S Hospital Of Los Angeles · P01 · FY2017 · CA
Project 1: Targeted sequencing and clinicopathology to evaluate primary melanoma molecular subtypes and outcomes
$328,084Marianne Berwick · University Of New Mexico Health Scis Ctr · P01 · FY2021 · CA
A Novel Pathway Involving E2F1, ATM and NBS1
$328,079David G. Johnson · University Of Tx Md Anderson Can Ctr · R01 · FY2006 · CA
Project 4
$327,992Paulo Cesar Rodriguez · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2023 · CA
Role of T Regulatory Cell Suppression in Autoimmunity and Cancer
$327,971Joost J Oppenheim · Division Of Basic Sciences - Nci · ZIA · FY2020 · CA
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer
$327,850Daniel G Gioeli · University Of Virginia · R01 · FY2018 · CA
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer
$327,850Daniel G Gioeli · University Of Virginia · R01 · FY2017 · CA
Effect of anti-S phase agents on human chromosomes
$327,850Anindya Dutta · University Of Virginia · R01 · FY2017 · CA
Effect of anti-S phase agents on human chromosomes
$327,850Anindya Dutta · University Of Virginia · R01 · FY2015 · CA
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer
$327,850Daniel G Gioeli · University Of Virginia · R01 · FY2016 · CA
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer
$327,850Daniel G Gioeli · University Of Virginia · R01 · FY2014 · CA
Checkpoint Signaling and Androgen Receptor Function in Prostate Cancer
$327,850Daniel G Gioeli · University Of Virginia · R01 · FY2015 · CA
Effect of anti-S phase agents on human chromosomes
$327,850Anindya Dutta · University Of Virginia · R01 · FY2016 · CA
Effect of anti-S phase agents on human chromosomes
$327,850Anindya Dutta · University Of Virginia · R01 · FY2013 · CA
Project 3 - Novel Therapies for Spliceosomal-Mutant MDS.
$327,755Matthew J Walter · Washington University · P50 · FY2022 · CA
The Role of pRB Family Members in Ras-mediated Tumorigenesis
$327,746Marie K Classon · Massachusetts General Hospital · R01 · FY2008 · CA
Project 3
$327,704John L. Cleveland · H. Lee Moffitt Cancer Ctr & Res Inst · P01 · FY2024 · CA